Xoterna Breezhaler

Xoterna Breezhaler is an inhaled medication combining glycopyrronium bromide and indacaterol maleate for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). This dual-action bronchodilator helps open airways and reduce symptoms like breathlessness. Ideal for daily use under medical supervision.

Xoterna Breezhaler is primarily used for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps manage symptoms such as wheezing, shortness of breath, and chest tightness by relaxing airway muscles. This medication is not intended for sudden breathing problems or acute asthma attacks.

Users of Xoterna Breezhaler may experience improved breathing comfort and reduced frequency of COPD symptoms over time. The medication works gradually to keep airways open, which can enhance daily activity levels and overall respiratory comfort. Individual responses may vary based on condition and adherence to the prescribed regimen.

Store Xoterna Breezhaler in a dry place away from direct sunlight and moisture. Keep the inhaler tightly closed when not in use to maintain its effectiveness. Always follow the handling instructions provided with the device to ensure proper administration. Consult a healthcare provider if you experience any issues with the inhaler or its use.

Xoterna Breezhaler may interact with other anticholinergic medications or beta-blockers, potentially increasing side effects like dry mouth or heart rate changes. Avoid using additional inhaled medications without consulting a healthcare provider. Alcohol and certain foods do not typically interact with this medication, but always disclose all medications to your doctor.